ArticleGeneral thoracic and cardiovascular surgery2026
Surgical outcomes of lung cancer associated with autoimmune disease-related interstitial pneumonia.
Article in General thoracic and cardiovascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic impact of the C-reactive protein-albumin-lymphocyte index in patients with resected lung cancer associated with interstitial pneumonia.Surgery today · 2026Article
- Surgical outcomes of lung cancer associated with autoimmune disease related interstitial pneumonia.General thoracic and cardiovascular surgery · 2026Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveGenerally, lung cancer originating from interstitial pneumonia (IP) is considered more aggressive; however, lung cancer in patients with autoimmune disease (AD)-related IP (AD-IP) is not well documented. This study aimed to clarify surgical outcomes and the risk of postoperative acute exacerbation (AE) in patients with lung cancer associated with AD-IP.
methodsWe retrospectively reviewed patients with lung cancer who underwent surgery between January 2011 and March 2021. Clinicopathological characteristics, recurrence-free survival (RFS), overall survival (OS), and perioperative outcomes were compared according to the presence of IP with or without AD.
resultsAmong 1281 patients with lung cancer, 61 (4.8%) had idiopathic interstitial pneumonia (IIP), 87 (6.8%) had AD without IP, and 26 (2.0%) had AD-IP. The 5-year RFS rates were 80.9% for patients without IIP or AD, compared with 48.0% for IIP, 76.1% for AD without IP, and 29.8% for AD-IP. The corresponding 5-year OS rates were 84.1%, 53.9%, 77.0%, and 34.5%. Patients with AD-IP were significantly younger (P = 0.001), were more often female (P < 0.001), had a lower % vital capacity (P = 0.002), and more frequently received preoperative steroids (P < 0.001). The overall incidence of AE among the 87 patients with IP was 10.3% (9/87): 9.8% (6/61) with IIP and 11.5% (3/26) with AD-IP, with no significant difference.
conclusionsLung cancer with AD-IP had a poor prognosis, as did lung cancer with IIP, and the frequency of postoperative AE of patients with AD-IP was as high as that in those with IIP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.